Rising clinical acceptance and expanding regulatory approvals for obesity indications fueled the segment dominance
FDA-approved labeling provides specific escalation schedules that should be followed carefully, with consideration for even slower titration in high-risk patients
distribution, release and actions
Other medications and interactions affecting your GLP-1 timeline Many GLP-1 users take other medications or supplements concurrently, and some of these interactions can affect how quickly or effectively the GLP-1 medication works
Disclose any history of pancreatitis, gallbladder problems, kidney disease, liver disease, severe digestive disease, or diabetic retinopathy
The medication was discontinued in 2008 for commercial reasons and is now available off-label only through licensed US compounding pharmacies with a prescription